The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Early results of a randomized phase II, compass trial to compare regimen and duration of neoadjuvant chemotherapy for gastric cancer.
Takaki Yoshikawa
No relevant relationships to disclose
Kazuaki Tanabe
No relevant relationships to disclose
Kazuhiro Nishikawa
No relevant relationships to disclose
Yuichi Ito
No relevant relationships to disclose
Takanori Matsui
No relevant relationships to disclose
Yutaka Kimura
No relevant relationships to disclose
Satoshi Morita
No relevant relationships to disclose
Yumi Miyashita
No relevant relationships to disclose
Akira Tsuburaya
No relevant relationships to disclose
Junichi Sakamoto
No relevant relationships to disclose